key: cord-0982912-b8c7q23s
authors: Ngo, Son Tung; Quynh Anh Pham, Ngoc; Thi Le, Ly; Pham, Duc-Hung; Vu, Van V.
title: Computational Determination of Potential Inhibitors of SARS-CoV-2 Main Protease
date: 2020-06-12
journal: J Chem Inf Model
DOI: 10.1021/acs.jcim.0c00491
sha: 0119324f1e24ccfe582fc896d56c6de3a3579587
doc_id: 982912
cord_uid: b8c7q23s

[Image: see text] The novel coronavirus (SARS-CoV-2) has infected several million people and caused thousands of deaths worldwide since December 2019. As the disease is spreading rapidly all over the world, it is urgent to find effective drugs to treat the virus. The main protease (Mpro) of SARS-CoV-2 is one of the potential drug targets. Therefore, in this context, we used rigorous computational methods, including molecular docking, fast pulling of ligand (FPL), and free energy perturbation (FEP), to investigate potential inhibitors of SARS-CoV-2 Mpro. We first tested our approach with three reported inhibitors of SARS-CoV-2 Mpro, and our computational results are in good agreement with the respective experimental data. Subsequently, we applied our approach on a database of ∼4600 natural compounds, as well as 8 available HIV-1 protease (PR) inhibitors and an aza-peptide epoxide. Molecular docking resulted in a short list of 35 natural compounds, which was subsequently refined using the FPL scheme. FPL simulations resulted in five potential inhibitors, including three natural compounds and two available HIV-1 PR inhibitors. Finally, FEP, the most accurate and precise method, was used to determine the absolute binding free energy of these five compounds. FEP results indicate that two natural compounds, cannabisin A and isoacteoside, and an HIV-1 PR inhibitor, darunavir, exhibit a large binding free energy to SARS-CoV-2 Mpro, which is larger than that of 13b, the most reliable SARS-CoV-2 Mpro inhibitor recently reported. The binding free energy largely arises from van der Waals interaction. We also found that Glu166 forms H-bonds to all of the inhibitors. Replacing Glu166 by an alanine residue leads to ∼2.0 kcal/mol decreases in the affinity of darunavir to SARS-CoV-2 Mpro. Our results could contribute to the development of potential drugs inhibiting SARS-CoV-2.

Members of the Coronaviridae virus family often cause mild respiratory syndrome in humans. 1 However, the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV) are transfected from animals to humans and cause severe cases of respiratory syndromes and deaths. 2, 3 In 2002, SARS-CoV was first recorded in Guandong, China, and linked to 8096 laboratory-confirmed cases of infection and 774 deaths. 3 The natural reservoir of SARS-CoV is Chinese horseshoe bats, 4 and intermediate hosts are civet cats and raccoon dogs. 5 This shows that Coronavirus can induce severe symptoms and potential pneumonia and death. In December 2019, a novel coronavirus (2019-nCoV or SARS-CoV-2) that has a similar sequence to SARS-CoV emerged in Wuhan, Hubei province, China. 6−8 The initial cluster of infection seemed to relate to Huanan seafood market. SARS-CoV-2 is thought to originate from bat. though the intermediate hosts are still unknown; 9 human-to-human transmission has been validated. 10 As of May 7, 2020, SARS-CoV-2 has infected more than 3,800,000 people and caused over 265,000 deaths worldwide. 11 Coronaviruses have the largest genomes among all known RNA viruses, ranging from 26 to 32 kb in length, which encode structural and nonstructural proteins. 12, 13 The SARS-CoV-2 genome encodes more than 20 proteins, which include the main protease (Mpro), a 3C-like protease (3CLP) that shares 96,1% similarity with 3CLP of SARS-CoV. 13, 14 Mpro, a homodimeric cysteine protease, plays an important role in SARS virus replication and transcription. When the mRNA of the virus is translated polyproteins, Mpro is first autocleaved to become a mature enzyme, which in turn cleaves all of the 11 remaining downstream nonstructural proteins of the polyproteins to polypeptides, which are required for the replication process of the virus. 13 SARS-CoV-2 Mpro has thus been an attractive drug target. 14, 15 Darunavir and ritonavir can potentially inhibit SARS-CoV-2 Mpro and have been put into clinical trials for COVID-19 treatment. 16, 17 Computer-aided drug design (CADD) is frequently used to estimate the probable inhibitors that could prevent the activity of an enzyme. This method significantly decreases the time and cost to develop a new drug. 18 Determination of the ligandbinding free energy is one of the most critical factors in CADD. 19 Many schemes were then developed to resolve this problem. 20 Typically, the ligand-binding affinity of several thousand ligands to a protein is frequently predicted via the molecular docking method; 21 a short list of these compounds would be then refined by using more computationally expensive binding free energy methods such as the molecular mechanism/Poisson−Boltzmann surface area (MM/PBSA), 22−24 linear interaction energy (LIE), 25, 26 or fast pulling of ligand (FPL) 27 approaches. The top-lead potential inhibitors will be finally confirmed via an accurate binding free energy approach as well as the free energy perturbation (FEP), 28, 29 thermodynamic integration (TI), 30, 31 and nonequilibrium molecular dynamics simulations (NEMD). 32 Especially, in some cases, calculations can be carried out by using a combination of Hamiltonian/temperature replica exchange molecular dynamics (REMD) simulations and the perturbation method. 33−36 In this work, we carried out computational investigations according to Scheme 1 to evaluate the potential inhibitors for SARS-CoV-2 Mpro. The obtained results could help enhance the development of SARS-CoV-2 therapy.

Structure of Complexes. The three-dimensional structure of SARS-CoV-2 Mpro was downloaded from https:// innophore.com/. 37 This modeled structure well superimposes the recent experimental structure with a C α RMSD smaller than 0.05 nm ( Figure S1 of the Supporting Information). 14 The G166A mutant ofSARS-CoV-2 Mpro was generated using the PyMOL mutagensis tools. 38 Molecular Docking Simulations. The molecular docking using the Autodock Vina package 39 was employed to rapidly determine the ligand-binding pose and affinity to SARS-CoV-2 Mpro with the exhaustiveness of 8 referring to the previous study. 40 The parameters of complexes were prepared using AutodockTools 1.5.6, 41 which were denoted in the PDBQT file. The atomic charges of both receptor and ligands were predicted via the Gasteiger−Marsili approach. 42, 43 The receptor and ligands were represented via a united atom model with explicit polar hydrogens. 44 The best docking mode was selected as the lowest obtained binding energy result. The grid center was selected as the center of mass of aza-peptide epoxide, which bound to the active site of SARS-CoV Mpro. 45 The grid size was chosen as 26 × 26 × 26 Å 3 .

Molecular Dynamics Simulations. GROMACS version 5.1.5 46 was employed to simulate the structural change of the solvated complex SARS-CoV-2 Mpro + inhibitor. The parameters for MD simulations were referred to the previous works. 36 SARS-CoV-2 Mpro was parametrized using the Amber99SB-ILDN force field. 47 Water molecules were parameterized using the Tip3p water model. Ligand structures were downloaded from the PubChem database. 48 The ligands were parametrized with the general Amber force field (GAFF) 49 using the combination of AmberTools18 50 and ACPYPE 51 protocols. The atomic charges were assigned using the restrained electrostatic potential (RESP) method 52 computed with quantum chemical calculation at the B3LYP double-hybrid functional and the 6-31G(d,p) basis set. The details of complexed configuration upon applied free energy methods were reported in the next subsection. The time steps of MD simulations were set to 2 fs. The electrostatic interaction was mimicked via the fast smooth particle-mesh Ewald electrostatics method. 53 The cutoff of the van der Waals (vdW) interaction was set at 0.9 nm. The temperature and pressure couplings were calculated using the V-rescale and Parrinello−Rahman schemes, respectively. The solvated complex was minimized using the steepest descent method. The energy minimized system was relaxed over 100 ps of NVT and 2 ns of NPT ensembles at 310 K. During the NVT and NPT simulations, C α atoms of the SARS-CoV-2 Mpro were softly retrained using a harmonic force. The coordinates of the solvated complexes were monitored over the atomistic simulations every 10 ps.

Free Energy Calculation. Fast Pulling of Ligand (FPL) Approach. The last snapshot of NPT simulations was used as the initial structure for SMD simulation. 27 Details of the computations were referred to the previous studies. 27 In particular, the (x, y, z) dimensions of the systems are (9.83, 5.92, 8.70) nm, as shown in Figure 1 . The systems in FPL simulations consist of 1 SARS-CoV-2 Mpro, 1 ligand, 15,000 water molecules, and Na + ions for a total of ca. 50,000 atoms. The pulling speed (v) and spring constant cantilever (k) were set at 0.005 nm ps −1 and 600 kJ mol −1 nm −2 , respectively. During the simulations, the C α atoms of Mpro were positionally restrained using a weak harmonic potential. A harmonic force was put on the center of mass of the inhibitor to disassociate it from the binding cavity of the SARS-CoV-2 Mpro ( Figure 1 ). The pulling force value and displacement of the ligand along the unbinding direction were monitored every 0.1 ps. The FPL Scheme 1. Computational Strategy to Determine the Probable Natural Inhibitors of SARS-CoV-2 Mpro simulations were repeated with eight independent trajectories to guarantee the sampling of simulations.

Free Energy Perturbation (FEP) Simulations. 54 The last snapshot of NPT simulations was used as the initial conformation for 20 ns long MD simulations. In particular, the SARS-CoV-2 Mpro + inhibitor complex was inserted into a dodecahedron periodic boundary condition (PBC) box with a volume of ca. 820 nm 3 . The complexed system comprises 1 SARS-CoV-2 Mpro, 1 ligand, 25,280 water molecules, and 4 Na + ions for a total of ca. 80,600 atoms. Moreover, the isolated inhibitor was inserted into a dodecahedron PBC box with a volume of ca. 85 nm 3 . The solvated ligand system consists of 1 ligand and ca. 2750 water molecules for a total of ca. 8300 atoms. The equilibrium conformation of MD simulations was then employed as the starting structure for FEP calculations according to the previous study. 36 During FEP simulations, the coupling parameter λ, which varies from 0 to 1, was employed to evaluate the free energy change ΔG of the system modification from the f ull-interaction state (λ = 0) to the noninteraction state (λ = 1) via the alteration of the systemic Hamiltonian between various circumstances. The change of a ligand from f ull-interaction to non-interaction states with surrounding molecules is called the ligand annihilation process ( Figure 2 ). Eight values of λ cou , including 0.00, 0.100, 0.20, 0.35, 0.50, 0.65, 0.80, and 1.00, were used to modify the Coulomb interactions. Nine values of λ vdW , including 0.00, 0.10, 0.25, 0.35, 0.50, 0.65, 0.75, 0.90, and 1.00, were used to alter the vdW interactions. Sixteen alter-λ simulations were performed to demolish a ligand from a solvated system ( Figure 2 ). The total energy change of the ligand annihilation process was then summed via the Bennet's acceptance ratio (BAR) method. 55 Finally, the absolute binding free energy between a ligand to SARS-CoV-2 Mpro was deduced as the different energy between two annihilation processes involving decoupling the ligand from the solvated ligand system and from the solvated protein−ligand system. Structural Analysis. A hydrogen bond (HB) is determined when an acceptor (A)−hydrogen (H)−donor (D) angle is larger than 135°and the A−D distance is less than 0.35 nm. A side-chain (SC) contact between inhibitors and SARS-CoV-2 Mpro is counted when the distance between non-hydrogen atoms of two molecules is less than 0.45 nm. The twodimensional interaction diagram between a protein and a ligand was generated using the LigPlot++ program. 56 Moreover, the pharmacokinetics of the top-lead compounds were predicted using the PreADME server. 57 ■ RESULTS AND DISCUSSION Potential Inhibitor Screening Using Molecular Docking. Autodock Vina 39 is one of the most popular free packages to roughly and rapidly estimate the binding affinity and binding pose of a trial inhibitor to an enzyme or a protein. The successful-docking rate of the package was up to 81% according to our previous benchmark study on over 800 protein−ligand complexes. 40 We used Autodock Vina to dock three previously reported ligands 14 to SARS-CoV-2 Mpro and obtained binding energies reasonably consistent with experimentally determined values (Table 1) . Therefore, in this project, Autodock Vina 39 was employed to rapidly evaluate the binding affinity of ca. 4600 natural compounds from the Vietherb database. 58 Because some current HIV-1 PR inhibitors, such as darunavir 16 or ritonavir, 17 have been tested for SARS-CoV-2 inhibition, eight drugs inhibiting HIV-1 PR, including amprenavir, atazanavir, darunavir, indinavir, lopinavir, nelfinavir, ritonavir, and saquinavir, were also investigated. Moreover, the binding of aza-peptide epoxide was also redocked to SARS-CoV-2 Mpro in order to compare with other ligands. The binding affinity of toplead compounds to SARS-CoV-2 Mpro is provided in Table S1 of the Supporting Information, respectively. The obtained docking energies fall in the range from −1.2 to −9.8 kcal/mol with a median of −6.22 ± 0.02 kcal/mol (the computed error is the standard error of the mean) ( Figure 3 ).

There are 35 natural compounds from the Vietherb database exhibiting a large ligand affinity to SARS-CoV-2 Mpro. The affinity of these compounds ranges from −8.6 to −9.8 kcal/mol (Table S1 in the Supporting Information), which is significantly larger than that found in the range of −6.4 to −7.6 kcal/mol for the eight HIV-1 PR inhibitors and aza-peptide epoxide. The 35 natural compounds form more HBs to SARS-CoV-2 Mpro than these nine compounds ( Figure 4 and Table S3 of the Supporting  Information) .

Refining Docking Results Using FPL Simulations. The obtained docking results were refined using the FPL method. 27 The FPL scheme is a very efficient technique to rapidly explore the binding affinity of a ligand to a protein, when the protein binding cavity is accessible to the exogenous ligand without sizable conformational change during the binding/unbinding process. The FPL approach requires a small amount of computing resource, but it could provide results with high accuracy and precision. 27 The maximum pulling force (F max ), called the rupture force, and the recorded pulling work (W) were used as a criterion to rank the ligand affinity. 27, 59 However, as mentioned in the previous work, 27 the pulling work is more appropriate than the rupture force, as it directly associates with the ligand-binding free energy via isobaric−isothermal Jarzynski equality. 60, 61 In this work, we carried out FPL simulations to rank the affinity to SARS-CoV-2 Mpro of 44 compounds screened with docking studies. The FPL calculations for 11r, 13a, and 13b 14 were also carried out for comparison. The equilibrated snapshot obtained from 2 ns of NPT simulations was used as an initial structure for the FPL simulations. The maximum pulling force, called the rupture force, and the pulling work were obtained from eight independent trajectories. The obtained results are provided in Table 2 . The mean of recorded rupture forces F max ranges from 416.9 ± 35.4 to 901.0 ± 59.2 pN. The timedependent pulling forces of these 47 systems are provided in Figure S3 of the Supporting Information. The form of pulling force curves are in good agreement with the previous studies, 27 in which the pulling forces continuously increase to maximum values before rapidly dropping to zero after the nonbonded contacts between the ligand to the protein were terminated. Here, the pulling work was selected as a criterion to rank the ligand affinity ( Figure 5 ). The average pulling work W ranges from 36.1 ± 4.5 to 104.0 ± 5.6 kcal/mol ( Table 2 ). The FPLderived pulling work for 11r, 13a, and 13b is 43.3 ± 3.9, 94.6 ± 5.0, and 91.9 ± 3.6 kcal/mol, respectively, which is consistent with respecttive experiments. 14 This result supports our approach in using FPL to refine the docking results.

A short list of potential inhibitors of SARS-CoV-2 Mpro was obtained and shown in Table 1 . The pulling work W for darunavir and ritonavir is 83.9 and 85.9 kcal/mol, respectively, which is >11% larger than that of the other HIV-1 PR inhibitors (Table 2) . Previous computational investigations suggested that lopinavir was able to prevent SARS-CoV-2 Mpro. 62 However, FPL results show otherwise, which is consistent with the recent clinical research. 63 Two natural compounds, cannabisin A and isoacteoside, have larger W values than that of ritonavir. Cannabisin A, Pubchem ID of 15086398, adopts the largest values of both W and F max , which are 104.0 kcal/mol and 901.0 pN, respectively. Isoacteoside, Pubchem ID of 6476333, has a pulling work W of 92.2 ± 4.4 kcal/mol. Besides these compounds, quercetin 7-O-rutinoside was also included in the list of potential inhibitors for the SARS-CoV-2 Mpro, because it adopts a W value of 79.4 ± 6.4 kcal/mol, which is only 5% smaller than that of darunavir. These five compounds adopt an appropriate pulling work W in comparison with that obtained for 13b (91.9 ± 3.6 kcal/mol), the most reliable SARS-CoV-2 Mpro inhibitor recently reported. 14 Validation of FPL Results Using FEP Calculations. Accurate and precise determination of the ligand-binding free energy probably reduces drug discovery cost. 64 Therefore, in order to validate the FPL results, the absolute binding free energy between five ligands was computed using the FEP (Table 3) , one of the most accurate and precise methods known to date. 20,65 FEP is often used in CADD, as it often provides results consistent with experiments. 66−68 The binding free energy of three recently reported inhibitors of SARS-CoV-2 Mpro, including 11r, 13a, and 13b, was also calculated. The good agreement between computational and experimental values 14 indicates that the FEP method is reliable in calculating the binding free energy of ligands to SARS-CoV-2 Mpro.

The equilibrium snapshots of the SARS-CoV-2 Mpro + inhibitor systems generated in NPT simulations were treated as the initial conformations for MD simulations. These MD simulations were set to run for 20 ns, in which all-atom RMSD of the complex was recorded every 10 ps ( Figure S4 of the Supporting Information). During the MD simulations, the binding pose between the SARS-CoV-2 Mpro and the inhibitor was refined under the effects of the interaction among them. The number of HBs between protein−ligand fluctuates from the Mean rupture force ΔF Max . b Mean pulling work W obtained from eight independent trajectories of SMD simulations. c Experimental binding free energy ΔG EXP roughly estimated based on the IC50 value reported recently, 14 assuming that the inhibition constant (k i ) is equal to the IC50 value. The error is the standard error of the mean. The unit of energy and work is kcal/mol; the unit of force is pN.

Journal of Chemical Information and Modeling pubs.acs.org/jcim Article beginning of MD simulations and becomes stable after 10 ns of MD simulations (Figure 6 ). It is consistent with all-atom RMSD of the complex over the MD simulations ( Figure S4 of the Supporting Information). Figure 7 shows the dominant structures and binding poses of cannabisin A and darunavir with SARS-CoV-2 Mpro, respectively. The poses for SARS- 14 assuming that the inhibition constant (k i ) is equal to the IC50 value. The error is the standard error of the mean values. The unit of energy and work is kcal/mol. The work values of the decoupling ligand from the solvated system are used to determine the free energy change over the annihilation ligand process (Figure 2 ). Sixteen λ-alteration MD simulations with a length of 2 ns were employed to calculate the work values. The soft-core potentials were used to characterize the altered Hamiltonian system. However, the soft-core potentials cost much more CPU time than the traditional one. Therefore, the performance of MD simulation is significantly reduced during λ-alteration simulations. In total, MD simulations were carried out in 219 ns over three trajectories. The free energy terms were then computed using the BAR method 55 over the interval 1−2 ns of the λ-alteration simulations with a period of 100 ps. Overall, the absolute binding free energy between five potential inhibitors to SARS-CoV-2 Mpro was then obtained (Table 3 ).

According to the results shown in Table 3 , the vdW free energy interaction energy dominates over the electrostatic free interaction energy during a ligand binding to SARS-CoV-2 Mpro. Moreover, darunavir adopts a stronger binding free energy (−11.96 ± 1.99 kcal/mol) to SARS-CoV-2 Mpro than ritonavir (−7.73 ± 1.77 kcal/mol). This result is consistent with recent clinical research 63 that ritonavir only has a weak inhibitory effect on SARS-CoV-2.

Quercetin 7-O-rutinoside, a compound from Platycodon grandiflorum, 58 exhibits poor binding affinity to SARS-CoV-2 Mpro (−5.52 ± 1.18 kcal/mol). Isoacteoside, a compound from Fernandoa adenophylla, 58 has a binding affinity of −9.40 ± 2.64 kcal/mol, which falls between that of ritonavir and darunavir. Cannabisin A, a compound from Cannabis sativa, 69 adopts the strongest binding affinity to SARS-CoV-2 Mpro (−12.76 ± 1.37 kcal/mol).

The FEP result suggests that canabisin A, isoacetoside, and darunavir are the potential inhibitors for SARS-CoV-2 Mpro, since their binding free energies are larger than that of compound 13b, which has a computational binding free energy of −9.18 ± 2.48 kcal/mol (Table 3 ). In addition, the cell membrane crossing ability was then predicted for these compounds using the preADMET server. The logP value predicted for canabisin A is 5.18, which is similar to that of ritonavir (5.59) and higher than that of darunavir (2.22). Having a logP value similar to an approved drug further supports canabisin A as a potential drug for SARS-CoV-2. In addition, the predicted logP value of isoacetoside is relatively small but is still on the positive side and should still be included in future study.

Potential Key Residue in SARS-CoV-2 Mpro−Ligand Binding. The potential important residues in SARS-CoV-2 Mpro−ligand binding could be probed via estimating the probabilities of SC and HB contacts between high-affinity inhibitors and individual residues of SARS-CoV-2 Mpro ( Figure  8) . Particularly, the residues His41, Met49, Leu141, Asn142, Ser144, Cys145, His164, Met165, Glu166, Leu167, and Gln189 formed SC contacts to the inhibitors in more than 80% of MD equilibrium snapshots. Interestingly, the inhibitors only adopt HB contacts to Glu166 over 81% of MD equilibrium snapshots. The mutation of this residue could possibly alter the binding affinity of a ligand to SARS-CoV-2 Mpro. To test this hypothesis, we have replaced Glu166 with an alanine residue and carried FEP calculation for the E166A SARS-CoV-2 Mpro + darunavir complex (Table 1) . Upon E166A mutation, the calculated binding affinity of darunavir to SARS-CoV-2 Mpro changes from −11.96 ± 1.99 to −9.90 ± 2.48 kcal/mol. This ∼2 kcal/mol decrease in binding affinity mostly arises from the weakening in coulomb interaction (ΔG cou ) due to the loss of HBs formed by the residue 166. This result suggests that G166 is potentially a key residue in ligand binding to SARS-CoV-2, and its mutation to a hydrophobic residue could lead to decreases in the inhibitory effect of ligands.

In this work, we utilized a rigorous computational approach to determine potential inhibitors of SARS-CoV-2 Mpro. First, we tested our approach on three recently reported inhibitors of SARS-CoV-2 Mpro and obtained computational results consistent with the experimental data. Subsequently, we investigated a database of 4600 natural compounds found in Vietnamese plants (Vietherbs). Eight HIV-1 PR inhibitors and an aza-peptide epoxide were added to the database. The database was first short-listed to 44 by molecular docking, which was further refined using FPL simulations to 5 compounds. The refined compounds were validated with the FEP method, the most accurate binding free energy estimation method. We found that two two natural compounds, cannabisin A and isoacteoside, in the Vietherbs database and an HIV-1 PR inhibitor, darunavir, can potentially inhibit SARS-CoV-2 Mpro, since their affinities are significantly larger than that of compound 13b, the most reliable SARS-CoV-2 inhibitor from the recent work. 14 Moreover, the other HIV-1 PR inhibitors are unlikely to prevent SARS-CoV-2 Mpro, consistent with a recent clinical study. 63 Furthermore, we also found that the residue Glu166 possibly plays an important role in the binding of a ligand to SARS-CoV-2 Mpro, which could be a target for future study.

The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.jcim.0c00491.

List of top-lead inhibitors for SARS-CoV-2 Mpro obtained via molecular docking; two-dimensional protein−ligand interaction diagram of top-lead compounds; superposition of modeled and experimental SARS-CoV-2 Mpro; superposition of experimental and docked conformations of compound 13b; FPL results; all-atom RMSD of SARS-CoV-2 Mpro + inhibitor systems; binding pose between SARS-CoV-2 Mpro + isoacteoside/quercetin 7-O-rutinoside/ritonavir obtained via MD simulations; and a docking list of all compounds to SARS-CoV-2 Mpro (PDF) Videos S1 and S2 describing the dynamics of SARS-CoV-2 Mpro + 13b or cannabisin A during MD simulations (MPG)

vn Duc-Hung Pham − Division of Immunobiology, Cincinnati Children's

vn Authors Ngoc Quynh Anh Pham − Faculty of Chemical Engineering

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

SARS and MERS: recent insights into emerging coronaviruses

Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats

Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern China

A novel coronavirus outbreak of global health concern

Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like Protease (3CLpro) Structure: Virtual Screening Reveals Velpatasvir, Ledipasvir, and Other Drug Repurposing Candidates

A Familial Cluster of Pneumonia Associated with the 2019 Novel Coronavirus Indicating Person-to-Person Transmission: a Study of a Family Cluster

WHO Coronavirus disease 2019 (COVID-19) Situation Report -52

) Fauquet, C. M.; Fargette, D. International Committee on Taxonomy of Viruses and the 3,142 unassigned species

Main Protease Provides a Basis for Design of Improved α-Ketoamide Inhibitors

Molecular Dynamic Simulations Analysis of Ritronavir and Lopinavir as SARS-CoV 3CLpro Inhibitors

Efficacy and Safety of Darunavir and Cobicistat for Treatment of Pneumonia Caused by 2019-nCoV (DACO-nCoV

Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia

Computer-Aided Drug Design

Ligand-Binding Affinity Estimates Supported by Quantum-Mechanical Methods

Docking Conformationally Flexible Small Molecules into a Protein Binding Site through Evolutionary Programming

Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models

Binding of a siverse set of ligands to avidin and streptavidin: an accurate quantitative prediction of their relative affinities by a combination of molecular mechanics and continuum solvent models

Computational study of protein specificity: the molecular basis of HIV-1 protease drug resistance

A New Method for Predicting Binding Affinity in Computer-Aidded Drug Design

Binding Affinities for Sulfonamide Inhibitors with Human Thrombin Using Monte Carlo Simulations with a Linear Response Method

Fast and Accurate Determination of the Relative Binding Affinities of Small Compounds to HIV-1 Protease using Non-Equilibrium Work

High-temperature equation of state by a perturbation method. I. Nonpolar gases

Free energy via molecular simulation: applications to chemical and biomolecular systems

Statistical Mechanics of Fluid Mixtures

Free energy calculations: applications to chemical and biochemical phenomena

Equilibrium free-energy differences from nonequilibrium measurements: A master-equation approach

Free Energy Perturbation Hamiltonian Replica-Exchange Molecular Dynamics (FEP/H-REMD) for Absolute Ligand Binding Free Energy Calculations

Computing Alchemical Free Energy Differences with Hamiltonian Replica Exchange Molecular Dynamics (H-REMD) Simulations

Reduced Free Energy Perturbation/Hamiltonian Replica Exchange Molecular Dynamics Method with Unbiased Alchemical Thermodynamic Axis

Oversampling Free Energy Perturbation Simulation in Determination of the Ligand-Binding Free Energy

Wuhan coronavirus 2019-nCoV − what we can find out on a structural bioinformatics level 2020

Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading

Autodock Vina Adopts More Accurate Binding Poses but Autodock4 Forms Better Binding Affinity

AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility

New Model for Calculating Atomic Charges in Molecules

Iterative Partial Equalization of Orbital ElectronegativityA Rapid Cccess to Atomic Charges

Crystal Structures of the Main Peptidase from the SARS Coronavirus Inhibited by a Substrate-like Aza-peptide Epoxide

High performance molecular simulations through multi-level parallelism from laptops to supercomputers

Motional Timescale Predictions by Molecular Dynamics Simulations: Case Study using Proline and Hydroxyproline Sidechain Dynamics

PubChem's BioAssay Database

Automatic Atom Type and Bond Type Perception in Molecular Mechanical Calculations

ACPYPE -AnteChamber PYthon Parser interfacE

Development and Testing of a General Amber Force Field

Particle mesh Ewald: An N· log(N) method for Ewald sums in large systems

High-temperature equation of state by a perturbation method. I. nonpolar gases

Efficient estimation of free energy differences from Monte Carlo data

Multiple Ligand− Protein Interaction Diagrams for Drug Discovery

The PreADME approach: Web-based program for rapid prediction of physico-chemical, drug absorption and drug-like properties

VIETHERB: A Database for Vietnamese Herbal Species

Top-Leads for Swine Influenza A/H1N1 Virus Revealed by Steered Molecular Dynamics Approach

Nonequilibrium Equality for Free Energy Differences

Calculating Potentials of Mean Force from Steered Molecular Dynamics Simulations

Potential COVID-2019 3C-like Protease Inhibitors Designed Using Generative Deep Learning Approaches

A Trial of Lopinavir−Ritonavir in Adults Hospitalized with Severe Covid-19

Binding Analysis of Some Classical Acetylcholinesterase Inhibitors: Insights for a Rational Design Using Free Energy Perturbation Method Calculations with QM/MM MD Simulations

Anti-Arrhythmic Medication Propafenone a Potential Drug for Alzheimer's Disease Inhibiting Aggregation of Aβ: In Silico and In Vitro Studies

Application of Free Energy Perturbation for the Design of BACE1 Inhibitors

In vitro and in silico determination of glutaminyl cyclase inhibitors

Cannabisin A, an arylnaphthalene lignanamide from fruits of Cannabis sativa